Series A vs Series B: Key Differences Explained

A Series A is typically a startup's first priced institutional venture round, raised after demonstrating product-market fit and early revenue traction. It's the round where a lead VC takes a board seat and the company transitions from 'figuring it out' to 'scaling what works.' Typical Series A profile: $1–3M ARR, 15–20%+ MoM growth, strong NRR, a defined ICP, and early evidence of a repeatable sales motion. Round sizes range from $8–25M, with pre-money valuations typically $20–80M. The Series A is the hardest round to raise for most founders — investors want traction but the company is still early enough to be risky. A16z, Sequoia, Benchmark, and similar top-tier funds primarily operate at Series A. Example: A SaaS company with $1.8M ARR and 18% MoM growth raises a $12M Series A at a $48M pre-money valuation. Mechanically, a Series A is a priced equity round: the company and the lead negotiate a pre-money valuation, and post-money equals pre-money plus the new capital, so the new investors' ownership is simply investment divided by post-money. The round is papered on NVCA-style documents — a charter creating Series A preferred stock with a 1x liquidation preference, an investor rights agreement, and voting and co-sale agreements — and it commonly includes an option-pool top-up baked into the pre-money, which shifts that dilution onto existing holders rather than the new money. It is also the round where governance formalizes: a real board, protective provisions, and quarterly reporting discipline arrive with the Series A whether or not the founders are ready for them.

A Series B is raised when a company has a proven growth model and needs capital to scale it aggressively. By Series B, the company typically has $5–20M ARR, a functioning sales and marketing machine, and a clear path to market leadership. Series B capital typically funds: expanding the sales team, entering new geographies, building out product, and sometimes M&A. Round sizes range from $20–60M, with pre-money valuations of $80–300M. Series B investors include both early-stage VCs doing follow-ons and growth-focused funds that didn't participate in Series A. The diligence process is more rigorous — investors expect detailed financial models, cohort analysis, and competitive landscape depth. Example: A company with $8M ARR and 120% NRR raises a $35M Series B at a $140M pre-money valuation to hire 30 enterprise AEs. The valuation logic shifts between the rounds. A Series A price is mostly a story about the future discounted by a competitive process — comparable-round benchmarks matter more than the company's own financials. A Series B price is anchored to the numbers: growth-adjusted ARR multiples, net revenue retention, burn multiple, and sales efficiency get pulled apart in diligence, and the multiple a company commands moves with the public-market comparables of its category. The investor mix shifts too: Series B rounds are frequently led by a new outside investor while the Series A lead exercises pro-rata rights to defend its ownership, and the presence — or conspicuous absence — of insider participation is itself a diligence signal for the new lead.

For founders, Series A is the pivotal round — it determines whether you have the metrics, team, and growth story to attract institutional capital. Most startups that fail to raise a Series A either ran out of money or couldn't demonstrate the growth needed. Understanding exactly what Series A investors look for (and setting those as your milestones with seed capital) is the most important strategic planning exercise a seed-stage founder can do. A useful planning discipline is to raise each round against the milestones of the next one: size the Series A to deliver the ARR scale, retention, and team the Series B market will demand with 6+ months of runway to spare, because raising into a miss compounds — a flat or down Series B resets both the valuation and the preference stack against the founders. The milestone bar between the rounds is the real gate; the valuation is just the scoreboard.

A startup hits $1.5M ARR with 110% NRR and raises a $15M Series A. The capital goes toward hiring a VP Sales, 5 AEs, and a customer success team. 20 months later, ARR is $9M, NRR is 118%, and the sales team is consistently closing enterprise deals at $80K ACV. The company raises a $40M Series B. Now the goal is clear: 3x ARR in 24 months by expanding to Europe and moving upmarket to larger enterprise accounts. The playbook is proven — Series B buys the fuel to run it faster. Here is the dilution math across both rounds, tracked from the same starting cap table. Post-seed, the company is owned 70% by founders, 10% by the employee option pool, and 20% by seed investors. Series A: the company raises $12M at a $48M pre-money, so post-money is $60M and the new investors take $12M ÷ $60M = 20%. Every existing holder is diluted by the same factor of 0.80: founders go to 56%, the pool to 8%, seed to 16%. Two years later, Series B: $30M at a $120M pre-money, post-money $150M, new investors take $30M ÷ $150M = 20%. Everyone dilutes by 0.80 again — founders 44.8%, pool 6.4%, seed 12.8%, Series A 16%, Series B 20%. Across the two rounds the founders gave up 25.2 points of ownership, yet the value of their stake rose from $33.6M (56% of $60M) to $67.2M (44.8% of $150M) — exactly doubling. That is the trade both rounds are pricing: percentage down, value up, and the deal only works if the capital actually buys the growth. Note this example excludes option-pool top-ups; a 5-point pool refresh at either round would come out of the existing holders and deepen founder dilution further.